The Brain Tumor Center (BTC) at Memorial Sloan-Kettering held its first annual retreat on May 16, 2008, at the Tribeca Grand Hotel in downtown New York City. This was the first opportunity for all of the clinical and research groups with an interest in brain tumors to come together and look for areas of collaboration.
To kick off the event, the six recipients of the 2007 BTC Grants — Andrew Lassman, Michelle Bradbury, Luca Cartegni, Daniel Ciznadija, Adília Hormigo, and Michael McDevitt — presented the progress of their work. Following these presentations, representatives from six clinical departments — neurology, radiation oncology, neurosurgery, pediatrics, radiology, and the Human Oncology & Pathogenesis Program — gave updates about their departments' current scope of research in the field of brain tumors.
During the afternoon session, there was a poster session where senior faculty members were able to comment and make recommendations on postdoctoral trainees' research projects. In addition, Robert Lowman, Associate Chancellor for Research and Director of Research Services at the University of North Carolina at Chapel Hill, gave a presentation on how to receive funding from foundations.
The meeting was attended by members of the BTC external advisory committee who helped to make recommendations to BTC executive leadership — including Paul Mischel from UCLA and Luis Parada from Southwestern Medical Center — who delivered the keynote speech on the role of NF1 in central and peripheral nervous system tumors.
By all accounts, the meeting was a great success for team building, information sharing, and developing strategies for the near and long-term future.
Click here to download the retreat agenda.